Trade OXFORD BIOMEDICA PLC ORD 50P - OXB CFD
What is Oxford BioMedica plc (OXB)?
Oxford BioMedica plc is a biopharmaceutical company specializing in the development of gene and cell therapies. The company focuses on creating treatments for serious diseases by leveraging its proprietary lentiviral vector technology platform. Oxford BioMedica collaborates with pharmaceutical and biotechnology partners to develop and manufacture gene therapy products. Its expertise encompasses vector design, process development, and clinical manufacturing. The company operates in the advanced therapy medicinal products sector, contributing to the development of innovative treatments for conditions such as cancer and genetic disorders. Oxford BioMedica's activities include research and development, manufacturing, and licensing. The company is subject to regulatory oversight applicable to biopharmaceutical development and production.
Oxford BioMedica plc Stock Price Today: Live Overview
The price today is shaped by trading activity, as Oxford BioMedica plc is currently priced at £5.696. The session's range extends from £5.384 to £5.614, with a daily change percentage of +1.6382%.
FAQ: Oxford BioMedica plc (OXB)
What is the current price of OXB stock?
The current value is £5.696.
Does OXB pay dividends?
No dividends are paid by the company.
Does OXB have a formal corporate presence or regional headquarters in the UAE?
Oxford BioMedica plc has a registered presence in the Dubai International Financial Centre (DIFC), UAE.
What is OXB best known for?
Oxford BioMedica plc is most famous for its gene and cell therapy technologies.
What assets are typically shown together with OXB?
Commonly shown alongside OXB: IWG, Rumble Inc, China Resources Building Materials Technology Holdings Limited
Latest shares articles



